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The objective of this work was to evaluate the inﬂuence of varying the concentrations of the wall ma-
terials (soy protein isolate/gum Arabic, SPI:GA), the ratio of the wall material to the core material and the
concentration of the reticulating agent (TG) in the production of omega-3 ethyl ester microcapsules by
complex coacervation, using a central compound rotational design (CCRD) and analyzing the results by
response surface methodology (RSM). The only dependent variable capable of obtaining a mathematical
model was encapsulation process yield, which has a maximum peak at C5 (2.6:1.0 wall:core and 1.8:1.0
SPI:GA). The trials C12 (1.5:1.0 SPI:GA; 1.0:1.0 wall:core; 6.0 UA of TG/g) and C14 (1.5:1.0 SPI:GA; 2.0:1.0
wall:core; 10.0 UA of TG/g) would have to add 0.40 g or 0.45 g of microcapsules to 100 g or 100 mL
portions of foods for them to be considered as having functional properties, respectively.
 2013 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction
There is an increasing demand for natural bioactive compounds
that preserve the health and reduce the risk of disease (Augustin
et al., 2011). The beneﬁcial effects of the long chain omega-3
polyunsaturated fatty acids (LCPUFA n-3), (EPA; C20:5; n-3) and
docosahexanoic acid (DHA; C22:6; n-3) are well documented,
showing various beneﬁts to human health, including a reduction in
the risks of cardiovascular diseases, anti-cancerigenous activity,
anti-inﬂammation effects, prevention of osteoporosis and neuro-
logical disturbances (Alzheimer’s disease, Crohn’s disease, etc.),
also helping to reduce the incidence of depression (Abeywardena &
Head, 2001; McLennan & Abeywardena, 2005; Riediger, Othman,
Suh, & Moghadasian, 2009; Weitz, Weintraub, Fisher, &
Schwartzbard, 2010; Wendel & Heller, 2009).
Omega-3 polyunsaturated fatty acids are highly susceptible to
oxidation. This factor, associated with the resistance of various
consumer groups to eat foods that are sources of omega-3, mainly
cold water ﬁsh, has led to the development of techniques such as
microencapsulation that facilitate incorporation of these in-
gredients in food formulations (Ackman, 2006).
The coacervation process is an alternative to microencapsula-
tion for compounds sensitive to high temperatures and to certainx: þ55 019 32893617.
e Conto).
sevier OA license.organic solvents, being a physicochemical process that does not use
organic solvents nor require drastic temperatures. It is normally
used to encapsulate solid or liquid ingredients that are insoluble in
water, and is therefore indicated to encapsulate omega-3 rich oils
(Goiun, 2004). According to Ma et al. (2009), complex coacervation
is a phase separation process for the production of insoluble com-
plexes, based on the simultaneous dissolution of polyelectrolytes
with opposite charges, induced by changes in the medium. Nor-
mally the two biopolymers used include a protein molecule and a
polysaccharide molecule (Jun-xia, Hai-yan, & Jian, 2011).
Soy protein isolate (SPI) has been used with success in the
microencapsulation of hydrolyzed casein by spray drying (Molina-
Ortiz et al., 2009), of essential orange oil by complex coacervation
(Jun-xia et al., 2011) and of ﬁsh oil by an enzymatic jelliﬁcation
process (Cho, Shim, & Park, 2003; Serna-Saldivar, Zorrilla, La Parra,
Stagnitti, & Abril, 2006). Studies carried out by Kim andMorr (1996)
indicated that SPI showed greater compatibility with gum Arabic
than with other polymers.
The microparticles produced by complex coacervation, despite
the advantage of encapsulating large amounts of corematerial (85e
90 g/100 g), present low mechanical and heat resistance due to the
ionic nature of the interactions between thewall forming polymers,
and thus it is necessary to strengthen the wall by reticulation,
generally involving the protein, which can be done using chemical
or enzymatic reticulating agents (Burgess & Ponsart, 1998). The
enzyme transglutaminase (TG) is a protein reticulating agent
permitted for use in foods. TG (E.C. 2.3.2.13) catalyzes acyl transfer
Table 1
Matrix of the experimental design for the variables of SPI:GA concentration, core material concentration and TG concentration in the production of omega-3 fatty acid ethyl
ester microcapsules by complex coacervation, with the respective results for encapsulation yield and efﬁciency, free oil content, mean particle size and total EPA þ DHA
content.
Trial x1 x2 x3 SPI:GAa Wall:Corea TGa
(UA/g)
Process
yield (g/100 g)
Encapsulation efﬁciency
(g/100 g)c
Free lipid material
(g/100 g)b
Mean particle
size (mm)b
Total EPA þ
DHA (g/100 g)
C1 1 1 1 1.8:1.0 2.6:1.0 3.62 51.18 53.27B  7.08 3.02J  0.28 51.93BCDE  2.74 8.26
C2 1 1 1 1.2:1.0 2.6:1.0 3.62 43.97 33.82DEF  6.94 4.08IJ  0.14 48.12FGH  2.44 5.75
C3 1 1 1 1.8:1.0 1.4:1.0 3.62 43.17 50.37BCD  4.35 5.07HI  0.53 50.91CDEF  3.38 13.32
C4 1 1 1 1.2:1.0 1.4:1.0 3.62 38.83 40.13BCDE  6.55 10.08E  1.30 45.85HI  2.52 14.37
C5 1 1 1 1.8:1.0 2.6:1.0 8.38 53.79 62.60BC  0.87 2.46J  0.89 56.48A  2.08 7.34
C6 1 1 1 1.2:1.0 2.6:1.0 8.38 42.71 24.96EF  3.81 3.14IJ  0.40 48.32FGH  1.73 4.23
C7 1 1 1 1.8:1.0 1.4:1.0 8.38 41.13 34.88BCDEF  8.57 7.78G  1.07 50.34CDEFG  1.81 12.42
C8 1 1 1 1.2:1.0 1.4:1.0 8.38 36.82 24.25EF  0.62 6.77GH  0.16 49.68DEFG  3.00 9.52
C9 1.68 0 0 2.0:1.0 2.0:1.0 6.00 50.92 25.20CDEF  5.64 10.86E  0.53 52.30BCDE  2.38 12.15
C10 þ1.68 0 0 1.0:1.0 2.0:1.0 6.00 35.21 19.81F  2.03 8.01FG  0.18 49.18EFGH  2.54 7.22
C11 0 1.68 0 1.5:1.0 3.0:1.0 6.00 46.89 41.53B  8.56 3.27IJ  0.79 44.27I  2.59 6.71
C12 0 þ1.68 0 1.5:1.0 1.0:1.0 6.00 42.07 45.98BCD  7.94 21.89A  0.61 50.23CDEFG  3.50 25.64
C13 0 0 1.68 1.5:1.0 2.0:1.0 2.00 45.44 22.23F  2.88 9.88EF  0.08 46.81GHI  1.78 10.19
C14 0 0 þ1.68 1.5:1.0 2.0:1.0 10.00 47.97 70.77A  4.90 15.31CD  0.09 54.85AB  0.29 22.27
C15 0 0 0 1.5:1.0 2.0:1.0 6.00 47.38 26.52BCDEF  6.80 17.73B  0.62 53.79ABC  2.20 16.62
C16 0 0 0 1.5:1.0 2.0:1.0 6.00 48.01 26.73BCDEF  7.80 16.11BC  0.86 53.75ABC  2.29 13.18
C17 0 0 0 1.5:1.0 2.0:1.0 6.00 47.48 27.13BCDEF  2.79 13.54D  1.10 53.42ABC  1.38 15.86
C18 0 0 0 1.5:1.0 2.0:1.0 6.00 47.26 27.57BCDEF  4.52 13.90D  0.48 53.07ABCD  2.27 14.62
C19 þ1.68 e þa 1.0:1.0 e 10.00 50.09 51.13BCDEF  2.92
C20 þ1.68 0 e 1.0:1.0 2.0:1.0 e 44.53 30.35CDEF  0.58 16.31BC  0.77 50.98BCDEF  3.29 15.50
a SPI ¼ Soy protein isolate; GA ¼ gum Arabic; Core material ¼ Fatty acid ethyl ester; TG ¼ transglutaminase.
b The results represent the means of three determinations. Samples followed by the same letters in the same column do not differ (p  0.05) by Tukey’s test.
c The results represent the means of ﬁve determinations. Samples followed by the same letters in the same column do not differ (p  0.05) by Tukey’s test.
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peptides and primary amines mainly by covalent bonds between
glutamine and lysine residues, and its efﬁciency in forming cross
links depends on the molecular structure of the protein (Chambi &
Grosso, 2006; Grifﬁn, Casadio, & Bergamini, 2002).
The objective of the present work was to evaluate the inﬂuence
of varying the concentrations of the wall materials (soy protein
isolate and gum Arabic, SPI:GA), the ratio of the wall material to the
corematerial and the concentration of the reticulating agent (TG) in
the microencapsulation of omega-3 polyunsaturated fatty acid
ethyl esters by complex coacervation using a central compound
rotational design (CCRD), analyzing the results by response surface
methodology (RSM) and Tukey test for comparison of means with
the control trials.
2. Material and methods
2.1. Materials
Fish oil ethyl ester e EE e (62 g EPA þ DHA/100 g ﬁsh oil ethyl
ester, Vital Atman, Uchoa, SP), soy protein isolatee SPIe (The Solae
Company, Porto Alegre, RS, Brazil, 88 g protein/100 g SPI), Instat-
gum gum Arabic AA e GA e (Acácia Senegal e CNI Colloides
Naturais Brasil Comercial Ltda, São Paulo, SP, Brazil), Trans-
glutaminase Activa TG-S e TG e (Ajinomoto, Limeira, SP, Brazil).
2.2. Methods
2.2.1. Microcapsule production
In order to produce the multinucleated microcapsules by com-
plex coacervation, the conditions were pre-determined in relation
to the raw materials and process according to Table 1 (ﬁrst seven
columns). The processing parameters adapted from Jun-xia et al.
(2011) are described in the following steps:
1. The soy protein isolate was added to 70 mL deionized water to
give the concentration determined by the experimental design
(Table 1) and stirred in an ultrasound bath for 10 min for
dissolution.2. The ﬁrst emulsion was made with the core material and dis-
solved soy protein isolate in an Ultra-turrax homogenizer (IKA-
Werke Ultra-turrax model T18 basic, Germany), with agitation
at 20,000 rpm for 1 min.
3. Fifty milliliters of a 7 g/100 g solution of gum Arabic was then
added to the emulsion, the volume completed to 150 mL with
deionized water, and the mixture heated at 45 C with mag-
netic stirring.
4. As indicated by Jun-xia et al. (2011), the pH was adjusted to the
coacervation pH 4.0 by adding 0.5 mol/L and 0.1 mol/L HCl
solutions with magnetic stirring.
5. The coacervation systemwas cooled in an ice bath to 10 Cwith
magnetic stirring, in approximately 3 h.
6. The reticulation process was carried out by adding the enzyme
TG to the system, dissolved in 100 mL deionized water at the
concentration described in the experimental design (Table 1),
maintaining the system at 10 C for 20 h in a BOD chamber
(Eletrolab, Brazil).
7. The microcapsules were washed three times with deionized
water and once with ethanol, ﬁltering through Whatman
qualitative ﬁlter paper n4 (porosity 20 mm).
8. The microcapsules were dried in a Pirani 50 freeze dryer
(Edwards, USA) for 24 h.2.2.2. Encapsulation process yield and efﬁciency
The encapsulation process yield was determined using Equation
(1):
%Yield ¼ Mass of the freeze dried microcapsulesðdwbÞ  100
Initial mass of the polymers and core materialðdwbÞ
(1)
The encapsulation efﬁciency was obtained after acid degrada-
tion of the capsules by adding 0.2 g of sample to 4.5 mL boiling
deionized water plus 5.5 mL 8 mol/L HCl, and leaving in a boiling
water bath for 30 min (until complete degradation of the wall
material). The mixture was then ﬁltered and washed with 10 mL
boiling deionized water. The ﬁlter paper with the hydrolyzed
Table 2
Analysis of variance (ANOVA) of the mathematical model for encapsulation yield of
microcapsules produced with SPI and GA by complex coacervation.
Source of
variation
Sum of
squares
Degrees of
liberty
Mean
square
F calculateda F calc/F tab
Regression 388.85 9 43.21 10.09 2.98
Residue 34.26 8 4.28
Lack of ﬁt 33.9366 5 9.0628 83.854
Pure error 0.3283 3 0.1081
Total SS 423.1102 17
a Level of signiﬁcance of 95% (p  0.05).
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odology for the determination of oil content for protein rich foods
(AOCS Ac 3-44, 2004). The encapsulation efﬁciency was determined
according to Equation (2) as described by Davidov-Pardo, Roccia,
Salgado, León, and Pedroza-Islas (2008).
%Encap:efficiency ¼ ðTotal lipid content freeEE contentÞ100
Total lipid content
(2)
where the methodology of Velasco, Dobarganes, and Márquez-Ruiz
(2000), with some adaptations to the scale, was used to extract the
free EE. To determine the free EE, 0.8 g of microcapsules were added
to 20 mL of petroleum ether and shaken for 15 min at 25 C. The
microcapsules were then ﬁltered through anhydrous Na2SO4, the
solvent evaporated off and the samples dried in nitrogen.
2.2.3. Morphology of the microcapsules
The morphology of the microcapsules was determined using a
model TM 3000 high vacuum scanning electronic microscope
(SEM) (Hitachi, Japan), with a magnitude of 15 to 3000 (digital
zoom 2, 4) and accelerating voltage of 15 kV (Analy mode). A high
sensitivity BSE detector of the semi-conductor was used with a
turbomolecular pump: 30 L/sx1 units, diaphragm pump. The
samples were arranged on aluminum stubs containing a double-
faced copper tape to secure the material. The best ﬁelds were
selected, where the microcapsules were isolated.
2.2.4. Extraction of free EE
Extraction of free EE followed methodology described in 2.2.2.
2.2.5. Microcapsule size distribution and mean size
The mean size and size distribution of the microparticles were
obtained using the Mastersizer 2000 (Malvern Instrument LTDA,
Worcestershire, UK). Three readings were taken, with three repe-
titions, giving a total of nine evaluations, shaking at 3500 rpmwith
25% of ultrasound stirring used to better dispersion of the
microcapsules.
2.2.6. Constitution of the EE
The lipid material was extracted from microcapsules that had
not passed through the process to remove free ethyl esters (EE),
aiming to analyze the composition of the fatty acids in this fraction.
The wall material was destroyed as described by Velasco et al.
(2000), and the samples used to obtain the methyl esters of the
fatty acids using the method described by Hartman and Lago
(1973), adapted for use with microcapsules.
The fatty acid composition was determined by the AOCS Ce 1e
62 (2004) method, using a CGC Agilent 6850 Series GC capillary
gas chromatograph system equipped with the following capillary
column: DB-23 Agilent (50% cyanopropyl) e methylpolysiloxane,
dimensions 60 m, internal diameter 0.25 mm, ﬁlm 0.25 mm. The
operating conditions were as follows: ﬂow rate ¼ 1.0 mL/min;
linear velocity of 24 cm/s; detector temperature of 280 C; injector
temperature of 250 C; oven temperature of 110C-5 min/110e
215 C e 5 C/min/215 C ¼ 34 min; stripping gas: helium; vol-
ume injected 1.0 mL; split 1:50.
2.2.7. Amount of n-3 EE encapsulated
In order to have a graphical and numerical viewof the amount of
n-3 EE encapsulated was determined using the mean results of
total lipid content obtained to calculate the encapsulation efﬁ-
ciency (2.2.2), which were multiplied by the EPA þ DHA concen-
tration obtained in the fatty acid composition (2.2.6).2.2.8. Statistical analysis
The evaluation of the effects of different concentrations of wall
material (SPI:GA e x1), core material (wall:core e x2) and reticu-
lating agent (TG e x3) on the characteristics of the EE microcap-
sules, was carried out using the STATISTICA 7.0 (StatSoft, Inc., Tulsa,
OK, USA) software, following a 23 central compound rotational
design (CCRD), with 6 axial points and 4 central points, verifying
the possibility of analyzing the results by response surface meth-
odology, where the results of regression coefﬁcients to encapsula-
tion process yield were determined. The same program and trials
were used for the means comparison test (verifying differences
between trials 19 and 20) by the analysis of variance (ANOVA) and
Tukey’s test, at a signiﬁcance level of 95% (p  0.05).3. Results and discussion
3.1. Encapsulation process yield and efﬁciency
Table 1 shows the values obtained for encapsulation process
yield and encapsulation efﬁciency, and Table 2 shows the analysis
of variance of the mathematical models obtained for encapsulation
process yield.
Equation (3) shows the complete regression model (R2 ¼ 0.92;
Fcalc/Ftab¼ 2.98) obtained for the encapsulation process yield (EY).
Based on the coefﬁcient of determination (R2), the regressionmodel
explained 92% of the responses.
EY ¼ yi ¼ 47:56 3:91x1  1:72x21  2:91x2  1:22x22 þ 0:11x3
 0:43x23 þ 1:21x1x2  0:48x1x3  0:68x2x3 ð3Þ
Fig. 1 shows the response surfaces and contour curves obtained
for encapsulation process yield, which showed that the effects of
the wall material (SPI-GA) concentration and the wall material to
core material ratio (wall:core) presented more signiﬁcant effects
than the other variables.
Fig.1 shows that the smaller the corematerial concentration and
the higher the SPI:GA ratio, the higher the encapsulation process
yield, the maximum value being obtained for C5 (1.8:1.0 SPI:GA;
2.6:1.0 wall:core; 8.38 UA de TG/g) approximately 54 g/100 g. These
results corroborate those cited in the literature. Jun-xia et al. (2011)
found the maximumvalues for encapsulation yield when they used
only 10 g/100 g core material (orange essential oil) in relation to the
wall material (SPI:GA), the values falling with increases in core
concentration. Lamprecht, Schafer, and Lehr (2001) obtained close
to 90 g/100 g encapsulation yield for capsules of ﬁsh oil ethyl esters
encapsulated in amatrix of gelatin andGA by complex coacervation.
These results, which were the best ones, were obtained at concen-
trations of 1.0:1.0 of wall material:core material, and when they
increased the concentration of core material, the yield declined.
The low values obtained for encapsulation process yield and
encapsulation efﬁciency in the present study can be explained by the
Fig. 1. Pareto diagram, representing the effects, response surface and contour curve
obtained for the dependent variable of encapsulation process yield (6.0 UA of TG/g)
where: EY ¼ encapsulation process yield; SPI ¼ soy protein isolate; GA ¼ gum Arabic.
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systems, even after using ultrasound to improve the solubility of the
protein (Mendanha et al., 2009; Molina-Ortiz et al., 2009). Another
possible explanation is the fact that the pH was not altered in each
trial to obtain stoichiometric equilibrium between the charges, andFig. 2. Scanning electronic microscopy of the EE microcapsules produced with SPI and GA b
C9 ¼ 2.0:1.0 SPI:GA; 2.0:1.0 wall:core; 6.0 UA of TG/g; C12 ¼ 1.5:1.0 SPI:GA; 1.0:1.0 wall:core
SPI:GA; 2.0:1.0 wall:core; 6.0 UA of TG/g; C20 ¼ 1.0:1.0 SPI:GA; 2.0:1.0 wall:core; 0 UA of Twas hence distant from the ideal zeta potential. According to Jun-xia
et al. (2011), a pH of 4.0 was the ideal value for systems formed from
the biopolymers SPI:GA with a core material of orange essential oil,
based on the encapsulation yield and absorbance of the supernatant
observed in the pH range between 2.5 and 4.5.
The analyses of the effects of the concentration of the wall
materials (SPI:GA), the wall material to core material ratio (wall:-
core) and the TG concentration on the encapsulation efﬁciency,
failed to present acceptable regression coefﬁcients (R2 < 55%) for
obtaining mathematical models considering the independent var-
iables under study, even though the repeatability of the results was
proven by the central point trials (C15, C16, C17 and C18e1.5:1.0
SPI:GA; 2.0:1.0 wall:core; 6.0 UA of TG/g), which did not present
statistical differences between them (p > 0.05).
In the comparison of the experimental trials with the control
trials (C20 e without TG), the trial C14 (1.5:1.0 SPI:GA; 2.0:1.0
wall:core; 10 UA/g TG) showed the highest encapsulation efﬁ-
ciency of approximately 70 g/100 g, differing statistically from the
others (p < 0.05). Lamprecht et al. (2001) obtained lower results of
60% encapsulation efﬁciency for capsules of ﬁsh oil ethyl ester
encapsulated in a matrix of gelatin:GA by complex coacervation,
although they managed to get elevated results for encapsulation
efﬁciency.
3.2. Microcapsule morphology
The formation of microcapsules of fatty acid ethyl esters was
conﬁrmed by SEM. All the trials presented the same topographical
conformation, with accentuated wrinkling and the presence of
smaller microcapsules adhering to the surfaces, a characteristic
better observed in Fig. 2. Tang and Li (2012) also observed indented
and wrinkled surface morphology of microcapsules produced with
SPI by spray drying process, very similar to those found in this
work, and justiﬁed this fact by uneven shrinkage during the drying
or the surface protein content of your wall.
The presence of microcapsules with incomplete parts can be
observed (C9), a fact also observed by Jun-xia et al. (2011), who
indicated the need for more extensive studies in relation to they complex coacervation where: C4 ¼ 1.2:1.0 SPI:GA; 1.4:1.0 wall:core; 3.62 UA of TG/g;
; 6.0 UA of TG/g; C14 ¼ 1.5:1.0 SPI:GA; 2.0:1.0 wall:core; 10.0 UA of TG/g; C17 ¼ 1.5:1.0
G/g.
Fig. 3. Particle size distribution of the freeze dried microcapsules obtained by complex
coacervation where: C18 ¼ 1.5:1.0 SPI:GA; 2.0:1.0 wall:core; 6.0 UA of TG/g;
C19 ¼ 1.0:1.0 SPI:GA; 0 wall:core; 10.0 UA of TG/g; C20 ¼ 1.0:1.0 SPI:GA; 2.0:1.0
wall:core; 0 UA of TG/g.
Fig. 4. Chromatographic proﬁle of the fatty acid composition of the ﬁsh oil ethyl esters
in the microcapsules where: C16:0 ¼ palmitic acid; C18:0 ¼ stearic acid; C18:1 ¼ oleic
acid; C18:4 ¼ stearidonic acid; C20:1 ¼ gadoleic acid; C20:5 ¼ eicosapentanoic acid;
C22:3 ¼ docosatrienoic acid; C22:5 ¼ docosapentanoic acid; C22:6 ¼ docosahexanoic
acid. The sample shown is that of trial C12 (1.5:1.0 SPI:GA; 1.0:1.0 wall:core; 6.0 UA of
TG/g).
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cracks could represent the non-sealing and incomplete formation
of the microcapsules.3.3. Free EE content
The analyses of the effects of the concentration of the wall ma-
terials (SPI:GA), the wall material to core material ratio (wall:core)
and the TG concentration on the free EE content failed to present
acceptable regression coefﬁcients (R2 < 70%) for obtaining mathe-
matical models considering the independent variables under study.
Table 1 shows that C12 presented the highest free EE content,
statistically differing from the other trials (p < 0.05), possibly
because this trial had the highest concentration of core material
tested. Trials C1, C2, C5, C6 and C11 presented the lowest values for
free EE content, and the highest values for the ratio of wall material
to core material.
Lamprecht et al. (2001) obtained different results for free EE
after reticulation with different chemical agents and by spray
drying, varying from 4.3 to 28.2 g/100 g Davidov-Pardo et al. (2008),
working with soy protein isolate by the enzyme gelation process
obtained values above 5 g/100 g for free ﬁsh oil.3.4. Microcapsule size distribution and mean size
The analyses of the effects of the concentration of the wall
materials (SPI:GA), the wall material to core material ratio(wall:core) and the TG concentration on the mean particle size,
failed to present acceptable regression coefﬁcients (R2 < 75%)
for obtaining mathematical models considering the independent
variables under study, even though the repeatability of the re-
sults was proven by the central point trials (C15, C16, C17 and
C18e1.5:1.0 SPI:GA; 2.0:1.0 wall:core; 6.0 UA of TG/g), which did
not present statistical differences between them (p > 0.05). The
values obtained for the mean particle size can be seen in Table 1.
The size of microparticles produced by complex coacervation
using the polymer pair of gelatin and gum Arabic is affected by
many parameters, such as the stirring rate, solution viscosity, core/
polymer ratio, amount of water, etc (Inoue, Kawai, Kanbe, Saeki, &
Shimoda, 2002). According toMascarenhas (2010), p.167, a reduced
relative dispersion of the particle size can be noted when the mi-
crocapsules are produced under controlled conditions, when
compared to those produced in the ice bath, that is, controlling the
cooling rate resulted in particles with greater uniformity of size
amongst them. However, according to Mukai-Correa et al. (2003),
the particles produced by complex coacervation can vary from 1 to
500 mm. The variation in mean particle size obtained in this study
could possibly be explained by small differences in the cooling
temperature during the production process, and by variations in
the concentrations of the polymers and core material used, altering
the viscosity of the dispersions.
Lamprecht et al. (2001) obtained results of about 40 mm for
microcapsules of ﬁsh oil encapsulated in a matrix of gelatin:GA by
complex coacervation. On the other hand, Jun-xia et al. (2011)
obtained a mean result of 7.569 mm for microcapsules produced
with SPI:GA by coacervation. These differences could be justiﬁed
by the different process conditions used by each author, princi-
pally the stirring velocities used (6000 rpm/5 min). Many studies
have shown that the greater the stirring velocity the smaller the
particle size, with greater encapsulation efﬁciency (Jegat &
Taverdet, 2000; Mascarenhas, 2010, p. 167; Tirkkonen, Turakka,
& Paronen, 1994).
The particle size distribution followed a unimodal distribution,
with a tendency to normality in all the trials. Fig. 3 shows the
histograms obtained for a trial at the center point (C18e1.5:1.0
SPI:GA; 2.0:1.0 wall:core; 6.0 UA of TG/g) and for the controls C19
and C20, these being representative of all the trials.
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In the gas chromatographic analysis of the fatty acids, the values
for EPA and DHA in the samples after extraction were approxi-
mately 55 g/100 g EPA þ DHA in the EE. Fig. 4 shows a represen-
tative chromatographic proﬁle of all the trials with the main fatty
acids identiﬁed, with the exception of trial C19, which had no
analyzable lipid material in its constitution. It can be seen that the
main fatty acids present were EPA, DHA and oleic acid, but can be
observed the presence of palmitic acid (C16:0), stearic acid (C18:0),
oleic acid (C18:1), stearidonic acid (C18:4), gadoleic acid (C20:1),
docosatrienoic acid (C22:3), docosapentanoic acid (C22:5). Ac-
cording to Hwang and Liang (2001), ﬁsh oil ethyl ester can be
constituted of 39e65 g/100 g of EPA and DHA.
3.6. Amount of n-3 EE in the microcapsules
The analyses of the effects of the concentration of the wall ma-
terials (SPI:GA), the wall material to core material ratio (wall:core)
and the TG concentration on the amount of n-3 EE in the micro-
capsules, failed to present acceptable regression coefﬁcients
(R2 < 70%) for obtaining mathematical models considering the in-
dependent variables under study. Table 1 shows the ﬁnal values
obtained for omega-3 (EPA þ DHA) in each trial, and it can be seen
that trial C12 (1.5:1.0 SPI:GA; 1.0:1.0 wall:core; 6.0 UA of TG/g) pre-
sented approximately 25 g of EPA þ DHA in 100 g of microcapsules,
followed by trial C14 (1.5:1.0 SPI:GA; 2.0:1.0wall:core; 10.0 UAof TG/
g),with 22.3 g of EPAþDHA in100 gofmicrocapsules. Thus basedon
theNational Agency for Sanitary Vigilance (ANVISAe BRASIL, 2009),
onewould need to add 0.40 g (C12) or 0.45 g (C 14) of microcapsules
to 100 gor 100mLportions of food in order to consider that it had the
appeal of a functional property, since the regulation states that foods
should present a minimum of 0.1 g EPA and/or DHA per 100 g or
100 mL portion to allow this allegation (ANVISA, 2009).
However, there are numerous recommendations for the daily
ingestion of omega-3 fatty acids published by various authors and
entities, some of which were listed by Whelan and Rust (2006).
According to these authors, in 1999 the British Nutrition Founda-
tion of the United Kingdom recommended the consumption of
1.25 g/day of total omega-3 fatty acids; in 2000, Simopoulos, Leaf &
Salem, 650 mg/day of EPA þ DHA; in 2002, the Scientiﬁc Advisory
Committee on Nutrition, also of the United Kingdom, >0.2 g/day of
omega-3 fatty acids; in 2003, the World Health Organization
(WHO), 1e2% of the calories coming from omega-3 fatty acids; in
2004, the International Society for the Study of Fatty Acids and
Lipids, 500 mg/day of EPA þ DHA. In 2004, the Food and Drug
Administration (FDA) of the USA allowed the allegation of func-
tional property for foods enriched with omega-3 fatty acids,
although also suggesting that the consumption of EPA þ DHA not
exceed 3 g/day due to possible adverse effects in the control of
glycemia, increase in bleeding time and of LDL-cholesterol.
4. Conclusions
The dependent variable of encapsulation process yield allowed
one to obtain a representative model, which has a maximum peak
at C5 (2.6:1.0 wall:core and 1.8:1.0 SPI:GA). The trials carried out
with 1.5:1.0 SPI:GA, 1.0:1.0 wall:core and 6.0 UA of TG/g and 1.5:1.0
SPI:GA, 2.0:1.0 wall:core and 10.0 UA of TG/g presented approxi-
mately 25 g and 22 g of EPA þ DHA n 100 g of microcapsules,
respectively. Thus it would be necessary to add 0.4 g or 0.45 g of
microcapsules to 100 g or 100 mL portions of foods to consider the
food as having the appeal of a functional property according to the
determinations of the national Agency of Sanitary Vigilance
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